245 related articles for article (PubMed ID: 3114551)
21. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
[TBL] [Abstract][Full Text] [Related]
22. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
[TBL] [Abstract][Full Text] [Related]
23. Results of treating 53 hairy cell leukemia patients with alpha-interferon.
Flandrin G; Castaigne S; Sigaux F; Degos L
Leukemia; 1987 Apr; 1(4):326-8. PubMed ID: 3669755
[TBL] [Abstract][Full Text] [Related]
24. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
Ehmann WC; Silber R
Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508
[TBL] [Abstract][Full Text] [Related]
25. Treatment of hairy cell leukemia with increasing doses of recombinant alpha A interferon.
Holmes R; Schwarz MA; Whiteside MG; Firkin FC
Aust N Z J Med; 1988 Jun; 18(4):557-62. PubMed ID: 3196242
[TBL] [Abstract][Full Text] [Related]
26. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
[TBL] [Abstract][Full Text] [Related]
27. Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN).
Lauria F; Foà R; Raspadori D; Zinzani PL; Buzzi M; Fierro MT; Bonferroni M; Fanin R; Gallizia C; Michieli MG
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):195-200. PubMed ID: 3356206
[TBL] [Abstract][Full Text] [Related]
28. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
[TBL] [Abstract][Full Text] [Related]
29. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission.
Quesada JR; Lepe-Zuniga JL; Gutterman JU
Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753
[TBL] [Abstract][Full Text] [Related]
30. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F
J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545
[TBL] [Abstract][Full Text] [Related]
31. Recombinant beta-serine-interferon in hairy cell leukemia compared prospectively with results with recombinant alpha-interferon.
Glaspy JA; Marcus SG; Ambersley J; Golde DW
Cancer; 1989 Jul; 64(2):409-13. PubMed ID: 2736487
[TBL] [Abstract][Full Text] [Related]
32. The UCLA experience with type I interferons in hairy cell leukemia.
Glaspy JA; Jacobs AD; Golde DW
Leukemia; 1987 Apr; 1(4):323-6. PubMed ID: 3312839
[TBL] [Abstract][Full Text] [Related]
33. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment.
Troussard X; Flandrin G
Leuk Lymphoma; 1994; 14 Suppl 1():99-105. PubMed ID: 7820062
[TBL] [Abstract][Full Text] [Related]
34. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
[TBL] [Abstract][Full Text] [Related]
35. [Beta interferon therapy in hairy cell leukemia].
von Wussow P; Dühlmann J; Grethlein T; Hirschmann WD; Hügl E; Koch O; Martin WR; Pees HW; Urbanitz W; Freund M
Klin Wochenschr; 1987 Jul; 65(14):688-90. PubMed ID: 3306139
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow changes in patients with hairy cell leukemia treated by recombinant alpha 2-interferon.
Naeim F; Jacobs AD
Hum Pathol; 1985 Dec; 16(12):1200-5. PubMed ID: 4065882
[TBL] [Abstract][Full Text] [Related]
37. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
Kuzmits R; Scheithauer W; Ludwig H; Flener R
Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
[TBL] [Abstract][Full Text] [Related]
38. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
[TBL] [Abstract][Full Text] [Related]
39. Treatment of hairy cell leukemia with alpha interferons.
Quesada JR; Gutterman JU; Hersh EM
Cancer; 1986 Apr; 57(8 Suppl):1678-80. PubMed ID: 3948137
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic procedure in hairy cell leukemia].
von Wussow P
Klin Wochenschr; 1987 Jul; 65(14):677-80. PubMed ID: 3114549
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
